Use of l-carnitine for the treatment of cardiovascular diseases

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/205 (2006.01) A61K 31/221 (2006.01) A61K 31/7004 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2569888

The use of L-carnitine, or one of its pharmaceutically acceptable salts, is described in combination with glucose for the preparation of a medicament useful for diminishing the number of deaths caused by acute myocardial infarction, for reducing the number of days infarction patients spend in intensive care in hospital, and for reducing the number of episodes of post- infarction heart failure, in which the L-carnitine is administered intravenously within only a few hours of the onset of symptoms of acute myocardial infarction at an initial dose of 9 grams a day in combination with 1000-1500 mL of a 5% glucose solution for 5 days, after which the L-carnitine treatment is continued at a dose of 4 grams a day administered orally.

L'invention concerne l'utilisation de la L-Carnitine ou de l'un de ses sels de qualité pharmaceutique en association à du glucose pour la préparation d'un médicament destiné à réduire le nombre de décès par infarctus aigu du myocarde, à réduire le nombre de jours que les patients victimes d'infarctus passent à l'hôpital en soins intensifs, et à réduire le nombre d'épisodes d'insuffisances cardiaques post.infarctus, dans lesquels la L-Carnitine est administrée en intraveineuse seulement quelques heures après l'appararition des symptômes de l'infarctus aigu du myocarde à une dose initiale de 9 grammes par jour associée à 1000-1500 mL d'une solution de glucose de 5% pour 5 jours, après quoi le traitement à base de L-carnitine est poursuivi à une dose de 4 grammes par jour administrée par voie orale.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of l-carnitine for the treatment of cardiovascular diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of l-carnitine for the treatment of cardiovascular diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of l-carnitine for the treatment of cardiovascular diseases will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1829970

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.